{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T08:10:03Z","timestamp":1746259803547,"version":"3.40.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1093\/jat\/bku058","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T07:10:28Z","timestamp":1402125028000},"page":"421-426","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Concomitant Methylphenidate and Opioid Use in Patients with Pain"],"prefix":"10.1093","volume":"38","author":[{"given":"Joy Y.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brookie M.","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candis M.","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia S.","family":"Atayee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,6,6]]},"reference":[{"key":"key\n\t\t\t\t20170720043542_BKU058C1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00365854","article-title":"A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics","volume":"3","author":"Wilwerding","year":"1995","journal-title":"Supportive Care in Cancer"},{"key":"key\n\t\t\t\t20170720043542_BKU058C2","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"American Family Physician"},{"key":"key\n\t\t\t\t20170720043542_BKU058C3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/jpmn.2001.25012","article-title":"Definition of and mechanism for opioid-induced sedation","volume":"00","author":"Young-McCaughan","year":"2001","journal-title":"Pain Management Nursing"},{"key":"key\n\t\t\t\t20170720043542_BKU058C4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3959(89)90169-3","article-title":"The cognitive effects of the administration of narcotic analgesics in patients with cancer pain","volume":"39","author":"Bruera","year":"1989","journal-title":"Pain"},{"key":"key\n\t\t\t\t20170720043542_BKU058C5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1345\/aph.1E309","article-title":"Pharmacologic treatment of opioid-induced sedation in chronic pain","volume":"39","author":"Reissig","year":"2005","journal-title":"Annals of Pharmacotherapy"},{"key":"key\n\t\t\t\t20170720043542_BKU058C6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"Journal of Pain"},{"key":"key\n\t\t\t\t20170720043542_BKU058C7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM199903113401007","article-title":"Treatment of attention-deficit-hyperactivity disorder","volume":"340","author":"Elia","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"key\n\t\t\t\t20170720043542_BKU058C8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2431-12-78","article-title":"The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care","volume":"12","author":"McCarthy","year":"2012","journal-title":"BMC Pediatrics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00003088-200140100-00004","article-title":"Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder","volume":"40","author":"Markowitz","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(25)00340-4","article-title":"Pharmacology of the enantiomers of threo-methylphenidate","volume":"241","author":"Patrick","year":"1987","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t20170720043542_BKU058C12","doi-asserted-by":"crossref","DOI":"10.1177\/1049909111427029","article-title":"Methylphenidate: established and expanding roles in symptom management","author":"Prommer","year":"2012","journal-title":"The American Journal Of Hospice And Palliative Care"},{"key":"key\n\t\t\t\t20170720043542_BKU058C13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00702-005-0437-7","article-title":"Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder","volume":"113","author":"Tucha","year":"2006","journal-title":"Journal of Neural Transmission"},{"key":"key\n\t\t\t\t20170720043542_BKU058C14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2011.03.026","article-title":"Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Kerr","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"key":"key\n\t\t\t\t20170720043542_BKU058C15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clinbiochem.2003.11.006","article-title":"Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods","volume":"37","author":"Eichhorst","year":"2004","journal-title":"Clinical Biochemistry"},{"key":"key\n\t\t\t\t20170720043542_BKU058C16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(92)90053-E","article-title":"Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain","volume":"48","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"key\n\t\t\t\t20170720043542_BKU058C17","first-page":"67","article-title":"Methylphenidate associated with narcotics for the treatment of cancer pain","volume":"71","author":"Bruera","year":"1987","journal-title":"Cancer Treatment Reports"},{"key":"key\n\t\t\t\t20170720043542_BKU058C18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpainsymman.2003.07.008","article-title":"Urine drug testing in pain medicine","volume":"27","author":"Heit","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"key":"key\n\t\t\t\t20170720043542_BKU058C19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jat\/bks020","article-title":"Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients","volume":"36","author":"Leimanis","year":"2012","journal-title":"Journal of Analytical Toxicology"},{"volume-title":"Chronic Pain Medical Treatment Guidelines","key":"key\n\t\t\t\t20170720043542_BKU058C20"},{"key":"key\n\t\t\t\t20170720043542_BKU058C21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/FTD.0b013e3181c11fba","article-title":"LC-MS\/MS extends the range of drug analysis in pain patients","volume":"31","author":"Mikel","year":"2009","journal-title":"Therapeutic Drug Monitoring"},{"key":"key\n\t\t\t\t20170720043542_BKU058C22","first-page":"273","article-title":"An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients","volume":"13","author":"Pesce","year":"2010","journal-title":"Pain Physician"},{"key":"key\n\t\t\t\t20170720043542_BKU058C23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3844\/ajptsp.2011.5.10","article-title":"Observations on the relationship between opioid medications, illicit drugs and heroin use in pain patients","volume":"6","author":"Yee","year":"2011","journal-title":"American Journal of Pharmacology and Toxicology"},{"key":"key\n\t\t\t\t20170720043542_BKU058C24","first-page":"489 pp","volume-title":"Primer of Biostatistics","author":"Glantz","year":"2002","edition":"5th edn"},{"key":"key\n\t\t\t\t20170720043542_BKU058C25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.72.1.56","article-title":"Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid","volume":"72","author":"Chan","year":"1983","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C26","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1991","journal-title":"Life Science"},{"key":"key\n\t\t\t\t20170720043542_BKU058C27","first-page":"711","article-title":"High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients","volume":"51","author":"Jaklic","year":"2013","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5055\/jom.2010.0023","article-title":"Observations of medication compliance by measurement of urinary drug concentrations in a pain management population","volume":"6","author":"West","year":"2010","journal-title":"Journal of Opioid Management"},{"key":"key\n\t\t\t\t20170720043542_BKU058C29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00008571-199810000-00005","article-title":"Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping","volume":"8","author":"Kashuba","year":"1998","journal-title":"Pharmacogenetics"},{"key":"key\n\t\t\t\t20170720043542_BKU058C30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00008571-200007000-00006","article-title":"Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates","volume":"10","author":"Labbe","year":"2000","journal-title":"Pharmacogenetics"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:49:17Z","timestamp":1746258557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article-lookup\/doi\/10.1093\/jat\/bku058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,6,6]]},"published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bku058","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"type":"print","value":"0146-4760"},{"type":"electronic","value":"1945-2403"}],"subject":[],"published":{"date-parts":[[2014,6,6]]}}}